Section of Congenital Heart Surgery, University of Arizona, Tucson, Ariz, USA.
J Thorac Cardiovasc Surg. 2013 Sep;146(3):599-604. doi: 10.1016/j.jtcvs.2012.03.088. Epub 2012 Aug 24.
Self-testing to determine the international normalized ratio improves management with warfarin and reduces the risks of adverse events. Self-testing usually begins several weeks after hospital dismissal after valve replacement. We aimed to compare the in-hospital initiation of international normalized ratio self-testing with usual care in mechanical heart valve recipients.
A total of 200 adult mechanical heart valve recipients were randomly assigned to in-hospital international normalized ratio self-testing instruction or usual care. Instruction for self-testing patients began on the fourth postoperative day. The patients were followed up for 3 months to compare the number of international normalized ratio tests, percentage of time in the therapeutic range, and adverse events.
The baseline characteristics were similar between the 2 groups. During the first 3 postoperative months, the usual-care group underwent an average of 10 international normalized ratio tests, and the self-testing group completed 14 international normalized ratio tests. The mean ± SD percentage of international normalized ratio tests within the therapeutic range was 45% ± 22% for the usual-care group and 52% ± 22% for the self-testing group (P = .05). Within 90 days after dismissal, transient ischemic attack occurred in 1 patient in the usual-care group and 2 patients in the self-testing group. Bleeding complications occurred in 3 patients in the usual-care group and 5 patients in the self-testing group.
Management of anticoagulation with warfarin after mechanical valve replacement is improved with self-testing, even during the early postoperative phase when international normalized ratio testing is performed frequently. Although the incidence of adverse events was similar in the 2 groups, better control of the international normalized ratio would be expected to improve outcome in large populations of patients.
自我检测国际标准化比值可改善华法林抗凝管理,降低不良事件风险。自我检测通常在瓣膜置换术后数周出院后开始。我们旨在比较机械心脏瓣膜置换术后患者住院期间开始国际标准化比值自我检测与常规护理的效果。
总共纳入 200 名成年机械心脏瓣膜置换术后患者,随机分为住院期间国际标准化比值自我检测指导组或常规护理组。自我检测患者组于术后第 4 天开始接受指导。对患者进行为期 3 个月的随访,比较国际标准化比值检测次数、治疗范围内时间百分比以及不良事件。
两组患者的基线特征相似。在前 3 个术后月内,常规护理组平均进行了 10 次国际标准化比值检测,自我检测组完成了 14 次。常规护理组国际标准化比值检测处于治疗范围内的平均(±SD)百分比为 45%±22%,自我检测组为 52%±22%(P=0.05)。出院后 90 天内,常规护理组有 1 例患者发生短暂性脑缺血发作,自我检测组有 2 例患者发生短暂性脑缺血发作。常规护理组有 3 例患者发生出血并发症,自我检测组有 5 例患者发生出血并发症。
即使在国际标准化比值检测频繁的术后早期阶段,机械性心脏瓣膜置换术后华法林抗凝管理的自我检测也能改善抗凝管理,提高治疗效果。尽管两组的不良事件发生率相似,但国际标准化比值的更好控制有望改善大患者人群的预后。